Rigvir® Cancer Treatment In Latvia Or At Home: How to Qualify, Treatment Period and Cost
If radiotherapy or chemotherapy no longer helps (or if you’re not willing to handle weight loss and fatigue), virotherapy with Rigvir® in its core might be the answer. Whether you’ve learnt about Rigvir® treatment from Truth About Cancer series or your local oncologist, take a minute to find out about:
- how to qualify for Rigvir® therapy?
- how long Rigvir® therapy lasts?
- how much Rigvir® therapy costs?
Riga virus was registered in Latvia in 2004, and in a year the medicine entered the pharmaceutical market. Since then, Rigvir® has reached 20 more countries while Latvia remains a medical and educational hub for Rigvir® treatment.
Reasons for Rigvir® Treatment in Latvia: the World’s Only Virotherapy Teaching Hub, Where the Chief Oncologist Is On the Team That Evaluates Cases
There are some more reasons to visit Latvia for virotherapy.
First of all, as Latvia is a home country for virotherapy, the local specialists have profound experience in treating cancer patients from Europe, Africa, North America, and Australia. Moreover, you’ll feel like home as both medical and administrative staff speaks English fluently.
Secondly, local oncologists blend theory and practice while teaching the specialists from other countries as Latvia is the world’s teaching hub for virotherapy. The Latvian oncologists share their knowledge about how Rigvir® works, what should be taken into account when evaluating the cancer case, how to manage follow-up programs etc.
Thirdly, when you apply for virotherapy treatment in Latvia, such experienced oncologists look into your medical documentation to assess your case and give personalized recommendations. The final decision is always taken by the Chief Oncologist of Latvia, who takes part in the assessment process.
Fourthly, flexibility is on your side: if you or your relative qualifies for Rigvir® therapy, you may choose to visit Latvia as an inpatient or get an outpatient care at home. Again, both options require that you first submit your medical files for the free case evaluation. Fill in the form on the right so we get back to you immediately with more details.
As for the mode of action, Rigvir® enters a human body through intramuscular injections. Being specifically designed to target cancer cells, Rigvir®:
- reaches and destroys them from the inside;
- doesn’t affect healthy cells located around the tumor;
- causes no side effects except for slightly higher than usual body temperature (37.5° C);
- is often used to prevent or get rid of metastases.
You Can Qualify For Rigvir® Treatment Once You Collect The Required Medical Reports
The 20th century has been marked with an invention made by Aina Muceniece, a Latvian scientist, who unveiled a virus ECHO-7 able to destroy cancer cells. The drug is now called Rigvir®, abbreviated from Riga virus, and is a nonpathogenic virus. It means that the virus injections will not cause any diseases.
There are two steps for you to take to find out whether you are eligible for Rigvir® treatment: find your cancer type on the list and collect your medical files.
For your convenience, the list can be copied:
- Biopsy (or pathology) report
- Cytology report
- CBC (complete blood count) + WBC (white blood cells) not older than 2 weeks
- Blood biochemistry incl. ALT (alanine aminotransferase), creatinine, etc.
- Radiology reports (actual images are not needed)
Whether you are searching for Rigvir for breast cancer or kidney cancer, the applying process is always the same. Once all the files are provided, it takes 2-3 business days for the team of oncologists and immunologists in Latvia to evaluate it. The assessment is necessary because it shows if virotherapy can improve your health condition.
If you get approved for the Rigvir therapy, here's what to expect:
Any questions? Click the button below and we’ll get in touch with you within 24 hours but usually immediately.
What Scientific Research and Patients Tell About Rigvir® Treatment
Not only scientific research, but virotherapy patients witness the improvement of their health condition.
Jane from the USA with ocular melanoma: "I chose not to do the conventional therapy in the United States."*
*Results may vary.
If you would like to know more how to apply for virotherapy from outside Latvia, read more about Rigvir in the USA and Rigvir in Canada. A course of virotherapy can be either a single tool to overcome the diseases or an addition to chemotherapy or radiotherapy. The survival rate in melanoma patients, who used Rigvir®, has raised in 4-6 times compared to those who didn’t, states the study published in Melanoma Research in October 2015: